Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Clinical trial NCT06419946 · RECRUITING
Trial details
- NCT number
- NCT06419946
- Sponsor
- Vastra Gotaland Region
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2031-12-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.